Cannabics Pharmaceuticals Inc. announced that it has filed 2 new Provisional Patent applications on Compositions and Methods for treating cancer, including colorectal cancer and early intervention therapy for colorectal cancer patients. These patent applications are now part of the Company's growing IP portfolio comprising of 8 Patent Families with 5 Granted patents and 19 Pending applications. Claims in Company's IP Portfolio include Pharmaceutical Compositions, Systems and Methods.